4TEEN4 begins trial of antibody therapy for cardiogenic shock
23rd July 2025 Uncategorised 0
First patient dosed in phase 1b/2a study of procizumab

More: 4TEEN4 begins trial of antibody therapy for cardiogenic shock
Source: News
First patient dosed in phase 1b/2a study of procizumab

More: 4TEEN4 begins trial of antibody therapy for cardiogenic shock
Source: News
© 1994 - 2026 B.M. Pharmaceuticals